Trial to Assess Chelation Therapy (TACT)

Completed · Phase 3 · Has a placebo group

Conditions studied: Coronary Artery Disease

In brief

The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.

Key facts

Study ID
NCT00044213
Run by
Mt. Sinai Medical Center, Miami
People needed
1708
Starts
2003-09-01
Expected to finish
2012-08-01
Last updated by the study team
2013-11-05

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.